Introduction
Alzheimer's disease (AD) is the most common progressive neurodegenerative disorder in elderly people. The extracellular deposition of β-amyloid (Aβ) plaques, intraneuronal tau pathology, synaptic loss, cholinergic neuronal cell death and inflammatory processes are the major neuropathological hallmarks of AD. A possible role for Ca 2+ dysregulation in the aging brain and in AD has been postulated [1, 2] . L-type calcium channels (LTCC) are assumed to be involved in Ca 2+ homeostasis [3] . LTCC consist of a pore-forming α 1 -subunit (Ca V 1.1, 1.2, 1.3 or 1.4), which plays a role in voltage sensing and serves as a drug-binding site. Auxiliary β-and α 2 δ-subunits are responsible for membrane trafficking and the modulation of channel properties [4, 5] .
Besides their occurrence in neurons, LTCC are also expressed by astrocytes [6] [7] [8] . After brain injury, glial cells become reactive and highly express glial fibrillary acidic protein (GFAP) [9] . In contrast, neuron-glial antigen 2 glia also reacts to degenerative stimuli but does not express GFAP [10] . It is well established that brain injury leads to an upregulation of Ca V 1.2 α 1 -subunits in reactive GFAPpositive astrocytes [11, 12] . The expression of Ca V 1.2 and Ca V 1.3 channels in primary astrocytes is well established [8, [13] [14] [15] , but their function is not completely understood. We have recently shown that Ca V 1.2 α 1 -subunits are highly expressed in reactive astrocytes surrounding Aβ plaques in a transgenic amyloid precursor protein-overexpressing mouse model [12, 16] . In addition, we have recently reported that reactive astrocytes around plaques do not coexpress the auxiliary β 4 -subunit [16] . The role and function of these calcium channels in astrocytes are not known. In order to investigate the role of astroglial LTCC channels, it would be necessary to explore the cellular regulation of all LTCC subunits in the astroglia. Unfortunately, no specific and immunohistochemically selective antibodies are available for most of the LTCC subunits.
The principal question arises whether astroglial Ca V 1.2 α 1 -subunit expression is caused by the AD pathology (including inflammation, oxidative stress or Ca 2+ dysregulation) or whether it is caused directly by plaque generation induced by the Aβ cascade. In the latter case, the question arises whether the plaques per se (containing aggregated Aβ peptides) or the soluble Aβ peptides alone may induce astroglial Ca V 1.2 α 1 -subunit expression. And third, it is possible that Ca V 1.2 α 1 -subunit expression is a consequence of the activation and reaction of the astrocytes rather than independent of plaques. In order to study these questions, we cultured primary astrocytes from the murine cortex to explore whether exogenous Aβ peptides directly regulate expression of the LTCC channel. We show that Aβ peptides moderately enhance LTCC expression after short incubation but decrease the expression after longer incubation.
Material and Methods

Animals
Male and female wild-type B6129SF2/J mice were purchased from the Jackson Laboratory (Bar Harbor, Minn., USA). All mice were housed according to standard animal care protocols, fed ad libitum with regular animal diet and maintained in a pathogenfree environment. All experiments were approved by the Austrian Ministry of Science and Research and conformed to the Austrian guidelines on animal welfare and experimentation.
Primary Astrocyte Cell Culture
Primary astrocytes were cultured as previously reported, with slight modifications [17, 18] . Postnatal-day 4 mice were rapidly sacrificed. The cortices were dissected and pooled in 1.5 ml of prewarmed sterile 0.25% trypsin solution. With a scalpel, the tissue was cut into small pieces. After an incubation time of 15 min at 37 ° C, the trypsin was discarded. To obtain single cells, the remaining tissue was passed through a 70-μm cell strainer (BD Falcon; Becton Dickinson, Franklin Lakes, N.J., USA) into a tube containing 1 ml of horse serum (16050-122; Gibco, USA) and 500 μl of DNase I (10 mg/ml; Roche Applied Sciences, Vienna, Austria). After 5 min of centrifugation (1,500 rpm), the pellet was resuspended in 10 ml of glial medium (5% horse serum, 0.5% FCS in 100 ml OptiMEM; Gibco). The cells were centrifuged again for 5 min at 1,500 rpm. The pellet was then resuspended in 2 ml of glial medium and transferred onto collagen-coated 6-well plates (150 μl of cells/well). The medium was changed 24 h after preparation and the cells were cultured for 2 weeks to become confluent. To remove residual microglia, the cells were shaken (180 rpm, 37 ° C) overnight and then again cultured in fresh medium. Astrocytes adhere to the surface, while other cell types peel off with the supernatant. We obtained a high astroglial purity with <0.1% oligodendrocytes or microglia.
Treatment with Exogenous Stimuli
Primary confluent astrocytes were incubated for either 3 days or 3 weeks by various treatments to induce cell activation: human Aβ 42 (10 μg/ml; Calbiochem, San Diego, Calif., USA); murine Aβ 42 (10 μg/ml; Calbiochem); the toxic Aβ 25-35 fragment (10 μg/ml; A4559; Sigma, St. Louis, Mo., USA); protein kinase C (PKC)-ε activator (3 μg/ml; DCP-LA, D5318; Sigma); and cAMP analog (12 μg/ml; Cpt-cAMP, C3912; Sigma). For some experiments, Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] treatments were performed at an acidic pH of 6.7 or with 45 μmol/l H 2 O 2 in order to enhance astrogliosis. The 3-week treatments were conducted with 1% horse serum in glial medium.
Immunohistochemistry
Immunohistochemistry was performed as described [16] . Astrocytes were fixed in cold 4% paraformaldehyde/10 mmol/l PBS (4 ° C, 30 min). After fixation, the cells were washed with PBS and then incubated with 0.1% Triton X-100/PBS (T-PBS) for 30 min at room temperature, shaking. Subsequently, the astrocytes were pretreated for 20 min with 5% methanol/1% H 2 O 2 /PBS, and after thorough rinsing, the cells were blocked with 20% horse serum/0.2% BSA/T-PBS. Finally, they were incubated for 2-3 days at 4 ° C with a primary antibody diluted in 0.2% BSA/T-PBS. The primary antibodies used for this study were: rabbit anti-Ca V 1.2 α 1 -subunit (1: 2,000; Sigma C1603); chicken anti-GFAP (1: 2,000; Millipore AB5541); and rabbit polyclonal to glutamine synthetase (1: 2,000; GluS; Abcam). After incubation, the cells were washed in PBS and incubated with biotinylated secondary antibodies: α-rabbit (1: 200; Vector V1011) or α-chicken (1: 200; Vector K0722). After 1 h of incubation, the astrocytes were washed with PBS and incubated with an avidin-biotin complex solution (Vectastain Elite ABC reagent; Vector Laboratories) for another 1 h. After washing with 50 mmol/l Tris-buffered saline, the signal was detected by using 0.5 mg/ml 3,3 ′ -diaminobenzidine including 0.003% H 2 O 2 as a substrate in Tris-buffered saline for 3-8 min. 26 ies, fluorescence immunohistochemistry was performed similarly as for chromogenic staining but without methanol pretreatment. After incubation with the primary antibody, the cells were washed in PBS and incubated with fluorescent Alexa 488 secondary antibodies (Invitrogen Life Technologies, Vienna, Austria). Additionally, DAPI staining was performed. After 1 h of incubation, the astrocytes were washed and ready for analysis.
RNA Isolation and Quantitative TaqMan-PCR
Quantitative RT-PCR was performed as recently described [16] . Astrocytes were rinsed quickly with PBS to remove the medium. Subsequently, by the addition of 600 μl of Buffer RLT (RNeasy Mini Kit; Qiagen, Hilden, Germany), cells were harvested with a cell scraper. Three wells from a 6-well dish were pooled. The astrocytes were disrupted by using QIAshredder columns, and total RNA was extracted utilizing the RNeasy Mini Kit. RNA concentrations were determined photometrically using BioPhotometer 6131 (Eppendorf, Hamburg, Germany). Reverse transcription was performed on 1 μg of RNA using SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, Calif., USA) and random hexamer primers (Promega, Madison, Wisc., USA). The RT mix was incubated for 60 min at 37 ° C. The relative abundance of different Ca V subunit transcripts was assessed by TaqMan quantitative PCR (qRT-PCR) using a standard curve method based on PCR products of known concentration in combination with normalization using the most stable control genes, as previously described [19] . TaqMan gene expression assays specific for all high-voltage-activated Ca 2+ channel subunits (α 1 , β and α 2 δ), designed to span exon-exon boundaries, were purchased from Applied Biosystems (Foster City, Calif., USA). The following assays (Applied Biosystems) were used [name (gene symbol), assay ID]: Ca V 1.1 (Cacna1s), Mm00489257_m1; Ca V 1.2 (Cacan1c), Mm00437953_m1; Ca V 1.3 (Cacna1d), Mm01209919_m1; Ca V 1.4 (Cacna1f), Mm00490443_m1; Ca V 2.1 (Cacna1a), Mm00432190_ m1; Ca V 2.2 (Cacna1b), Mm00432226_m1; Ca V 2.3 (Cacna1e), Mm00494444_m1; β 1 (Cacnb1), Mm00518940_m1; β 2 (Cacnb2), Mm00659092_m1; β 3 (Cacnb3), Mm00432233_m1; β 4 (Cacnb4) Mm00521623_m1; α 2 δ-1 (Cacna2d1), Mm00486607_m1; α 2 δ-2 (Cacna2d2), Mm00457825_m1; α 2 δ-3 (Cacna2d3), Mm00486613_ m1; and α 2 δ-4 (Cacna2d4), Mm01190105_m1. The endogenous control genes (Applied Biosystems) included were [name (gene symbol), assay ID]: γ-cytoplasmic actin (Actb), Mm00607939_s1; β 2 -microglobulin (B2m), Mm00437762_m1; glyceraldehyde-3-phosphate dehydrogenase (Gapdh), Mm99999915_g1; hypoxanthine phosphoribosyltransferase 1 (Hprt1), Mm00446968_ m1; succinate dehydrogenase complex, subunit A (Sdha), Mm01352363_m1; tata box-binding protein (Tbp), Mm00446973_ m1; and transferrin receptor (Tfrc), Mm00441941_m1. qRT-PCR (50 cycles) was performed in duplicates, using 20 ng total RNA equivalents of cDNA and the specific TaqMan gene expression assay for each 20-μl reaction in TaqMan Universal PCR Master Mix (Applied Biosystems). Analyses were performed using the 7500 Fast System (Applied Biosystems). The C t values for each Ca V gene expression assay were recorded for each individual preparation. To allow a direct comparison between expression levels in different tissues, we normalized all experiments to Tbp, Hprt1 and Actb, which were determined to be the most stably expressed reference genes across all preparations and time points [20] . Subsequently, normalized molecule numbers were calculated for each Ca V subunit from their respective standard curve [19] .
Data Analysis and Statistics
The data were organized and analyzed using MS Excel and KaleidaGraph statistical software. Statistical significance was determined by one-way ANOVA followed by the Fisher protected least significant difference (PLSD) post hoc test, and p < 0.05 represents significance.
Results
Astroglial Cultures
Immunohistochemistry for GFAP revealed a moderate staining of confluent astrocytes, while only occasionally, large reactive strong GFAP astrocytes were visible ( fig. 1 a, c) . Immunostaining for glutamate synthetase showed that the whole confluent layer was strongly positive ( fig. 1 b) . The reactive GFAP-positive astrocytes were also seen by fluorescent immunostaining over DAPI-positive nuclei ( fig. 1 e, f) . No expression of Ca V 1.2 α 1 -subunitlike immunoreactivity was seen in these astroglial cultures under all tested conditions ( fig. 1 d) .
Ca V 1.2 α 1 -Subunit mRNA Expression after Three Days of Incubation
Neither the PKC-ε activator DCP-LA nor the cAMP agonist affected mRNA expression of α 1 -subunits ( fig. 2 ). Human Aβ 42 had no effect on mRNA expression, while murine Aβ 42 slightly but significantly enhanced Ca V 1.2 and Ca V 1.3 α 1 -subunits ( fig. 2 ) . The toxic Aβ 25-35 fragment had no effect on expression of any tested α 1 -subunits ( fig. 2 ) . However, Ca V 1.3 was significantly decreased when costimulated with the toxic Aβ 25-35 fragment and H 2 O 2 ( fig. 2 ) .
Expression of Auxiliary Subunits after Three Days
In order to test expression of all auxiliary subunits in the primary astrocytes, we focused on murine Aβ 42 , which had a significant effect on Ca V 1.2 subunit expression. Among all auxiliary subunits tested, only β 2 and β 3 were significantly enhanced, while the mRNA for α 2 δ-2 was significantly downregulated by murine Aβ 42 ( fig. 3 ) . The PKC-ε activator DCP-LA significantly decreased Ca V 2.1, but not Ca V 1.2 and Ca V 1.3, subunit expression in primary murine astroglia ( fig. 4 ) .
Discussion
In the present study we found that Aβ peptides differentially regulate LTCC mRNA expression when incubated for a short (3 days) or long period (3 weeks).
Astroglial Cultures
It is assumed that astrocytes may contribute to several CNS pathologies, and reactive astrogliosis points to damaged tissue, which can easily be detected by GFAP staining, a reliable marker for activated astrocytes [9] . In addition, glutamine synthetase is another astroglia-specific staining. The primary astroglial culture model is well established in our research group [17, 18] , displaying a confluent layer with some GFAP-positive reactive astroglia, and <1% of other cells. In order to culture astroglia for a longer time period, the cells are cultured with low serum to prevent overgrowth of the cells and subsequent cell death. In order to enhance astrogliosis, in some experiments the cells were incubated at a low pH (6.7) or together with hydrogen peroxide.
Effects of PKC-ε Activator and cAMP Agonist on LTCC Subunits
It has been reported that PKC-ε overexpression increases the mRNA levels of Ca V 2.1 and Ca V 1.2 α 1 -subunits in primary astrocytes [13] . In addition, a novel PKC-ε activator, DCP-LA, reduced Aβ levels [21] , providing an im- 29 portant link to our Aβ experiments. Thus, as a control, we incubated our primary astrocytes with DCP-LA [21] . In fact, our data only showed a slight upregulation of the Ca V 1.2 subunit treated for 3 days with DCP-LA, while after 3 weeks, Ca V 2.1 was significantly downregulated. As another control, the effect of cAMP was tested, because it is well known that LTCC activity is regulated by cAMP production and subsequent activation of protein kinase A, involving β-adrenergic receptors [22, 23] . Further, increased cAMP levels in cultured astrocytes can convert flat polygonal astrocytes into process-bearing stellate astrocytes [24] . In order to increase intracellular cAMP, we used the highly membrane-permeable agonist cpt-cAMP. However, our data show that enhanced cAMP did not affect LTCC expression in primary astrocytes at all time points.
Effects of Acute (Three-Day) Aβ Treatment on α 1 -Subunits
We have recently shown that the Ca V 1.2 α 1 -subunit is highly expressed in GFAP-positive astrocytes surrounding Aβ plaques in an AD mouse model [16] . However, in this in vivo model, we cannot distinguish whether the peptides alone or the plaque per se may activate the calcium channels in these reactive astrocytes. Therefore, we aimed to investigate the mRNA expression levels of all LTCC subunits in primary astrocytes of postnatal mice. In the present study, we used 3 different Aβ peptides: human Aβ 42 , murine Aβ 42 and a toxic Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] amino acid fragment. We tested human and murine peptides because 3 amino acids are different between these two species [25] and it may be possible that human Aβ does not act on primary murine astrocytes. Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] was used because this small fragment is the main toxic component of the Aβ peptide. Previous work has shown that Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] induces cytoskeletal reorganization in cultured astrocytes [26] or revealed neurotrophic and neurotoxic effects on hippocampal neurons [27] . It was also suggested that this Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] peptide destabilizes calcium homeostasis and renders human cortical neurons more vulnerable to excitotoxicity [28] . All peptides were used at a very high concentration of 10 μg/ml because it has been reported that primary astrocytes are markedly affected under these conditions [29, 30] . Our present data show that the addition of murine Aβ 42 for 3 days slightly but significantly upregulated LTCC mRNA expression but not the protein of Ca V 1.2 and Ca V 1.3 in primary astrocytes. Thus, we conclude that an acute, brief exposure to Aβ does not markedly influence LTCC mRNA expression in cultured astrocytes. 
Effects on Auxiliary Subunits and Potentiation of Astrogliosis
In order to test whether the Aβ peptide activates auxiliary subunits in vitro (independent of the α 1 -subunit), we performed a qRT-PCR analysis of all subunits. We could identify that β 2 and β 3 were upregulated but α 2 δ-2 was downregulated after incubation with murine Aβ 42 for 3 days. This differential expression profile is difficult to explain, and still the signaling process in primary astrocytes is unknown. More experiments using electrophysiology with the patch clamp technique are required to further investigate this issue. In order to enhance the reactivity of primary astrocytes, we incubated the cells at a low pH (acidosis, pH 6.7) or treated the cells with a high concentration of hydrogen peroxide together with the toxic Aβ 25-35 fragment. Indeed, chronic hypoxia dramatically increased the current density of membrane channel proteins in HEK 293 cells [31] . It has also been reported that Aβ induces cell death by generation of H 2 O 2 [32] . However, costimulation with acidosis did not markedly affect mRNA expression of the LTCC subunits, while H 2 O 2 led only to a slight decrease in expression, suggesting that, again, another more robust mechanism may account for the calcium channel activation.
Long-Time Exposure of Primary Astrocytes with Aβ
Thus, we hypothesized that in order to enhance LTCC expression, primary astrocytes must be exposed to Aβ peptides for a longer time period. In addition, the higher Aβ concentration and longer incubation over 3 weeks at 37 ° C would also likely induce aggregation of Aβ peptides and provide more plaque-promoting conditions. In order to decrease dramatic proliferation, the primary astrocytes were cultured under low-serum conditions together with the Aβ peptides for 3 weeks. Unexpectedly, we observed that the Ca V 1.2 mRNA were significantly downregulated and again no Ca V 1.2 α 1 protein expression was seen. This suggests that neither soluble nor aggregated Aβ peptides alone are sufficient to induce a dramatic upregulation of the calcium channel in vitro. Thus, we conclude that more potent exogenous stimuli are necessary to activate calcium channels in reactive astrocytes in vitro, such as inflammation, oxidative stress and/or large Aβ plaques, or even an exposure for months. In fact, we have also shown in vivo that calcium channels are only upregulated at a very late stage (>11 months) in mice.
Conclusions
In conclusion, our data show that Aβ peptides differentially regulate LTCC mRNA expression in cultured primary cortical astrocytes when incubated for short and long periods. It seems likely that Aβ peptides alone are not sufficient to activate astroglial calcium channels. More robust long-lasting effects are necessary to activate Ca 2+ expression in GFAP-positive astrocytes.
